Search

Search Constraints

You searched for: Author/Creator Rubinstein, Mark P

Search Results

1. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Issue 5 (May 2018)

2. B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. Issue 1 (11th January 2022)

3. Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice. (6th November 2014)

5. Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies. (1st January 2021)

6. Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies. (1st January 2021)